92 results
Page 4 of 5
8-K
EX-99.1
ca9 94hl4n071je
14 May 20
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results
4:04pm
PRE 14A
kxrlhcdkyx
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-99.1
17q9z9lvc zni4dfwyko
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
424B5
usrfh
27 Mar 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
k18wbn a03z9c178d7
26 Mar 20
ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
8-K
EX-99.1
2dm0q7
10 Mar 20
ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
8:02am
424B3
uz89sn5
28 Jan 20
Prospectus supplement
4:59pm
8-K
EX-99.1
kare95erk5xdbr51
15 Jan 20
ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement
10:12am
8-K
EX-99.1
kata8h69qfgi649e40ck
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
8-K
EX-99.1
tro6v6mi8qj m7
13 Nov 19
ENDRA Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results
4:05pm
424B7
m79n83nw272b8pg
16 Sep 19
Prospectus with selling stockholder info
4:10pm